IL90161A0 - Expression of hepatitis b s and pres2 proteins in methylotrophic yeasts - Google Patents
Expression of hepatitis b s and pres2 proteins in methylotrophic yeastsInfo
- Publication number
- IL90161A0 IL90161A0 IL90161A IL9016189A IL90161A0 IL 90161 A0 IL90161 A0 IL 90161A0 IL 90161 A IL90161 A IL 90161A IL 9016189 A IL9016189 A IL 9016189A IL 90161 A0 IL90161 A0 IL 90161A0
- Authority
- IL
- Israel
- Prior art keywords
- hepatitis
- expression
- methylotrophic yeasts
- pres2
- proteins
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 title 1
- 208000006454 hepatitis Diseases 0.000 title 1
- 231100000283 hepatitis Toxicity 0.000 title 1
- 102100031673 Corneodesmosin Human genes 0.000 abstract 1
- 101710139375 Corneodesmosin Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Virology (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19371488A | 1988-05-13 | 1988-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL90161A0 true IL90161A0 (en) | 1989-12-15 |
Family
ID=22714736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL90161A IL90161A0 (en) | 1988-05-13 | 1989-05-02 | Expression of hepatitis b s and pres2 proteins in methylotrophic yeasts |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US5650296A (de) |
| EP (1) | EP0341746B1 (de) |
| JP (1) | JP2614314B2 (de) |
| KR (1) | KR100193701B1 (de) |
| CN (1) | CN1038668A (de) |
| AT (1) | ATE151109T1 (de) |
| AU (1) | AU618596B2 (de) |
| CA (1) | CA1340617C (de) |
| DD (1) | DD285373A5 (de) |
| DE (1) | DE68927921T2 (de) |
| DK (1) | DK235289A (de) |
| ES (1) | ES2101676T3 (de) |
| FI (2) | FI104639B (de) |
| GR (1) | GR3023985T3 (de) |
| HU (1) | HU207532B (de) |
| IE (1) | IE81158B1 (de) |
| IL (1) | IL90161A0 (de) |
| IN (1) | IN171696B (de) |
| MX (1) | MX26715A (de) |
| NO (1) | NO300465B1 (de) |
| NZ (1) | NZ228948A (de) |
| PL (1) | PL161997B1 (de) |
| PT (1) | PT90553A (de) |
| YU (1) | YU98689A (de) |
| ZA (1) | ZA893440B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5032516A (en) * | 1985-10-25 | 1991-07-16 | Phillips Petroleum Company | Pichia pastoris alcohol oxidase II regulatory region |
| PL168408B1 (pl) * | 1989-08-03 | 1996-02-29 | Smithkline Beecham Biolog | Sposób wytwarzania stransformowanego mikroorganizmu PL |
| US6197548B1 (en) | 1990-04-02 | 2001-03-06 | Medeva Pharma Limited | Transformed Pichia expressing the pertactin antigen |
| GB9007416D0 (en) * | 1990-04-02 | 1990-05-30 | Wellcome Found | Expression of heterologous protein in yeast |
| EP0521348A1 (de) * | 1991-06-18 | 1993-01-07 | Korea Institute Of Science And Technology | Chimerischer Antikörper, spezifisch für das Pre-S2 Oberflächenantigen des Hepatitis-B-Virus und Zellinie, die ihn produziert |
| LT3988B (en) | 1992-02-17 | 1996-06-25 | Fermentas Biotech Inst | Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof |
| CA2101610A1 (en) * | 1992-08-07 | 1994-02-08 | William D. Prevatt | Production of bacillus entomotoxins in methylotrophic yeast |
| GB9402832D0 (en) * | 1994-02-15 | 1994-04-06 | Smith Kline Beecham Biolog S A | Novel process |
| EP0889966A1 (de) * | 1995-11-09 | 1999-01-13 | ZymoGenetics, Inc. | Zusammensetzungen und verfahren zur herstellung heterologer polypeptide in pichia methanolica |
| US5955349A (en) * | 1996-08-26 | 1999-09-21 | Zymogenetics, Inc. | Compositions and methods for producing heterologous polypeptides in Pichia methanolica |
| US5716808A (en) * | 1995-11-09 | 1998-02-10 | Zymogenetics, Inc. | Genetic engineering of pichia methanolica |
| MX9605082A (es) | 1996-10-24 | 1998-04-30 | Univ Autonoma De Nuevo Leon | Levaduras metilotroficas modificadas geneticamente para la produccion y secrecion de hormona de crecimiento humano. |
| JP2008500364A (ja) * | 2004-05-25 | 2008-01-10 | キメラコア， インコーポレイテッド | 自己集合性ナノ粒子薬物送達システム |
| CN1704475A (zh) * | 2004-05-31 | 2005-12-07 | 成都生物制品研究所 | 羧端含前s2免疫决定簇的乙肝表面抗原融合基因及蛋白质 |
| JP2008507266A (ja) * | 2004-07-22 | 2008-03-13 | グライコフィ， インコーポレイテッド | ピチアにおける異種遺伝子発現のためのリンゴ酸シンターゼ調節配列 |
| CN100381171C (zh) * | 2004-12-30 | 2008-04-16 | 成都生物制品研究所 | 含前s1、前s2和s抗原决定簇的乙肝表面抗原复合颗粒 |
| WO2008108776A1 (en) * | 2006-04-07 | 2008-09-12 | Chimeros, Inc. | Compositions and methods for treating b- cell malignancies |
| AU2008236566A1 (en) * | 2007-04-09 | 2008-10-16 | Chimeros, Inc. | Self-assembling nanoparticle drug delivery system |
| WO2010120874A2 (en) | 2009-04-14 | 2010-10-21 | Chimeros, Inc. | Chimeric therapeutics, compositions, and methods for using same |
| JP2014527072A (ja) | 2011-09-09 | 2014-10-09 | バイオメド リアルティー， エル．ピー． | ウイルスタンパク質の集合を制御するための方法および組成物 |
| SG11201503059XA (en) | 2012-10-23 | 2015-06-29 | Toolgen Inc | Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR76274B (de) * | 1981-08-04 | 1984-08-04 | Univ California | |
| EP0401941A3 (de) * | 1984-07-11 | 1991-04-17 | Takeda Chemical Industries, Ltd. | Hepatitis B-Virus-Oberflächen-Antigen und seine Herstellung |
| US4895800A (en) * | 1985-11-26 | 1990-01-23 | Phillips Petroleum Company | Yeast production of hepatitis B surface antigen |
| US4816564A (en) * | 1986-01-31 | 1989-03-28 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
| JPS62236496A (ja) * | 1986-04-07 | 1987-10-16 | Green Cross Corp:The | ＨＢｓＡｇの製造方法 |
| US4963483A (en) * | 1987-10-13 | 1990-10-16 | Merck & Co., Inc. | Method for producing hepatitis B virus proteins in yeast |
| IL89991A0 (en) * | 1988-04-25 | 1989-12-15 | Phillips Petroleum Co | Expression of hepatitis b pres2 protein in methylotrophic yeasts |
-
1989
- 1989-05-02 NZ NZ228948A patent/NZ228948A/en unknown
- 1989-05-02 IL IL90161A patent/IL90161A0/xx unknown
- 1989-05-09 ZA ZA893440A patent/ZA893440B/xx unknown
- 1989-05-11 HU HU892372A patent/HU207532B/hu not_active IP Right Cessation
- 1989-05-11 NO NO891921A patent/NO300465B1/no not_active IP Right Cessation
- 1989-05-11 KR KR1019890006430A patent/KR100193701B1/ko not_active IP Right Cessation
- 1989-05-12 IE IE156389A patent/IE81158B1/en not_active IP Right Cessation
- 1989-05-12 DE DE68927921T patent/DE68927921T2/de not_active Expired - Lifetime
- 1989-05-12 ES ES89108632T patent/ES2101676T3/es not_active Expired - Lifetime
- 1989-05-12 AT AT89108632T patent/ATE151109T1/de not_active IP Right Cessation
- 1989-05-12 YU YU98689A patent/YU98689A/sh unknown
- 1989-05-12 AU AU34734/89A patent/AU618596B2/en not_active Expired
- 1989-05-12 PL PL89279426A patent/PL161997B1/pl unknown
- 1989-05-12 DK DK235289A patent/DK235289A/da not_active Application Discontinuation
- 1989-05-12 EP EP89108632A patent/EP0341746B1/de not_active Expired - Lifetime
- 1989-05-12 FI FI892312A patent/FI104639B/fi active IP Right Grant
- 1989-05-12 PT PT90553A patent/PT90553A/pt not_active Application Discontinuation
- 1989-05-12 DD DD89328581A patent/DD285373A5/de unknown
- 1989-05-12 MX MX2671589A patent/MX26715A/es unknown
- 1989-05-13 CN CN89103330A patent/CN1038668A/zh active Pending
- 1989-05-15 JP JP1121313A patent/JP2614314B2/ja not_active Expired - Fee Related
- 1989-05-15 CA CA000599724A patent/CA1340617C/en not_active Expired - Lifetime
- 1989-05-22 IN IN388/CAL/89A patent/IN171696B/en unknown
-
1995
- 1995-06-06 US US08/467,660 patent/US5650296A/en not_active Expired - Lifetime
- 1995-06-06 US US08/467,345 patent/US5670630A/en not_active Expired - Lifetime
-
1997
- 1997-07-02 GR GR970401639T patent/GR3023985T3/el unknown
-
1999
- 1999-11-29 FI FI992546A patent/FI107265B/fi not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA893440B (en) | Expression of hepatitis b s and pres2 proteins in methylotrophic yeasts | |
| GR3025382T3 (en) | Expression of human serum albumin in metholotrophic yeasts | |
| DE68929115D1 (de) | Verfahren zur Herstellung von menschlichem Serumalbumin in Hefe | |
| PH25120A (en) | Replicable expression vehicle and process of preparation thereof | |
| HUT43630A (en) | Mammalian interleukine-4 and process for producing it | |
| IL90035A (en) | Synthetic multimeric hepatitis b virus vaccine including both t cell and b cell determinants | |
| ZA892886B (en) | Expression of hepatitis b pres2 protein in methylotrophic yeasts | |
| DE68923496D1 (de) | Verfahren zur Herstellung von motilinähnlichen Polypeptiden und seine Expression. | |
| EP0339569A3 (de) | Expression vom HIV 24 KDA GAG Protein in methylotropischen Hefen | |
| JPS645492A (en) | Production of b type hepatitis virus protein in yeast | |
| IE891315L (en) | Expression of hepatitis b. pres2 protein in methylotrophic¹yeasts | |
| EP0503252A3 (en) | Recombinant proteins having the immunoreactivity of hepatitis b virus e antigens (hbeag), method for their production and their application in immunoassays and as vaccines |